ReviewInternational journal of heart failure2021

Angiotensin Receptor Neprilysin Inhibitors in HFrEF: Is This the First Disease Modifying Therapy Drug Class Leading to a Substantial Reduction in Diuretic Need?

Brian Kerr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.